Kyphosis Treatment Market - 2024-2031

Overview

Global Kyphosis Treatment Market reached US$ 1.3 billion in 2023 and is expected to reach US$ 2.1 billion by 2031, growing at a CAGR of 6.2% during the forecast period 2024-2031.

Kyphosis is the curvature of the spine that causes the top of the back to appear more rounded than normal. It might cause back pain and stiff muscles. There are nonsurgical and surgical treatment options available.

Kyphosis can affect the young and the old. It is brought on by different problems and can affect each patient differently. Kyphosis can be caused by degenerative diseases of the spine (such as arthritis or disk degeneration) as well as fractures caused by osteoporosis (osteoporotic compression fractures) and injury (trauma).

Market Dynamics: Drivers & Restraints

Advancements in treatment options

Physical therapy, bracing, and pain management techniques have evolved to give practical alternatives for patients who prefer non-invasive treatments, therefore expanding the entire therapeutic field. Biologic advancements such as stem cell therapy and platelet-rich plasma (PRP) injections can heal and regenerate tissues that have been damaged, resulting in better outcomes for kyphosis patients.

The development of innovative orthopedic devices and braces intended specifically to promote spinal alignment can improve therapy efficacy and patient comfort, hence boosting their use. Personalized treatment approaches for kyphosis result in improved management, higher patient satisfaction, and better outcomes.

Lack of awareness

Lack of awareness about the condition as well as the available treatment options is expected to hinder market growth and expansion. Patients might be unaware of the available treatment alternatives, both surgical and non-surgical, resulting in the underuse of effective therapies that could improve their quality of life.

Segment Analysis

The global kyphosis treatment market is segmented based on type, treatment type, distribution channel and region.

Scheuermann's kyphosis segment is expected to dominate the market share

The Scheuermann kyphosis segment holds a major portion of the market share and is anticipated to continue this trend during the forecast period. This is attributed to the increase in the geriatric population and incidences of the Scheuermann kyphosis diseases. Scheuermann's kyphosis (kye-FOH-sis) is an upper back condition. It gives the upper back a rounded appearance, giving the appearance of being hunched over. Scheuermann's disease is another name for it.

For instance, according to the report published by the National Institute of Health in 2023, it is stated that the prevalence of the disease in the United States is 1% to 8%. This increasing incidence is expected to contribute to the overall market growth. Increasing Scheuermann's kyphosis increases the demand for the treatment of the disease

Geographical Analysis

North America is expected to hold a significant position in the kyphosis treatment market share

North America is anticipated to dominate the kyphosis treatment market, globally. The factors attributed to the high growth of the region are the increasing number of kyphosis cases, increase in technological advancement, increase in genetic disorders and increase in geriatric population.

For instance, according to the report published by the National Institute of Health in 2023, it is stated that Scheuermann's Kyphosis (SK) is a rigid spinal kyphosis, which can occur the most and can contribute to the regional market expansion.

In addition, increasing strategies such as mergers and acquisitions and partnerships within key market players are expected to strengthen their product portfolio which will drive the market. Also, several product launches in the market will lead to lucrative growth of the market.

Market Segmentation

By Type

• Postural Kyphosis
• Scheuermann's Kyphosis
• Congenital Kyphosis

By Treatment Type

• Drugs
  • Aspirin
  • Ibuprofen
  • Naproxen
  • Acetaminophen
  • Others
• Devices
• Others

By Distribution Channel

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Salo Orthotics, AdvaCare Pharma, Boston Orthotics & Prosthetics, ScoliBrace, ALIMCO, NuVasive, Inc., Stryker Corporation, Mallinckrodt Pharmaceuticals, Wellona Pharma and Bayer AG among others.

Why Purchase the Report?

• To visualize the global kyphosis treatment market segmentation based on type, treatment type, distribution channel, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of kyphosis treatment market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global kyphosis treatment market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies